Results
7
Companies which are more than 50% undervalued based on analyst price target.
7 companies
Medios
Market Cap: €296.4m
Supplies specialty pharmaceutical drugs primarily in Germany.
ILM1
€11.62
7D
5.6%
1Y
-19.1%
M1 Kliniken
Market Cap: €284.6m
Provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia.
M12
€15.34
7D
10.4%
1Y
8.8%
Stratec
Market Cap: €280.8m
Designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally.
SBS
€23.05
7D
2.2%
1Y
-41.5%
MEDICLIN
Market Cap: €139.7m
Operates hospitals in Germany.
MED
€2.94
7D
0.7%
1Y
10.5%
LIMES Schlosskliniken
Market Cap: €82.7m
Operates private clinics for psychiatry, psychotherapy, and psychosomatics services in Germany, Switzerland, and Liechtenstein.
LIK
€266.00
7D
-4.3%
1Y
-24.0%
Pentixapharm Holding
Market Cap: €67.1m
Operates as a clinical-stage radiopharmaceutical development company.
PTP
€2.81
7D
0.5%
1Y
n/a
Geratherm Medical
Market Cap: €16.9m
Operates as a medical technology company in Germany.
GME
€3.01
7D
-10.1%
1Y
-28.3%